Compare SUPN & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | TRMD |
|---|---|---|
| Founded | 2005 | 1889 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 2010 | 2016 |
| Metric | SUPN | TRMD |
|---|---|---|
| Price | $48.78 | $27.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $61.60 | $34.00 |
| AVG Volume (30 Days) | 706.9K | ★ 1.0M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $392,755,000.00 | N/A |
| Revenue This Year | $23.19 | N/A |
| Revenue Next Year | $17.65 | N/A |
| P/E Ratio | ★ N/A | $9.61 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.16 | $13.63 |
| 52 Week High | $59.68 | $31.76 |
| Indicator | SUPN | TRMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.56 | 56.55 |
| Support Level | $47.95 | $21.54 |
| Resistance Level | $52.14 | $31.76 |
| Average True Range (ATR) | 1.99 | 0.91 |
| MACD | -0.58 | -0.17 |
| Stochastic Oscillator | 21.81 | 67.09 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
TORM plc operates as a shipping company mainly owning and operating a fleet of product tankers. It is engaged in the transportation of refined oil products and clean petroleum products, including gasoline, jet fuel, naphtha and diesel oil. The Company operates through two segments: the Tanker segment and the Marine Engineering segment, deriving the majority of its revenue from the Tanker segment.